CoChat
Sign Up
Cited by 351

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Exosome engineering in cell therapy and drug delivery

Sadeghi, Somaye, Tehrani, Fahimeh Ramezani, Tahmasebi, Safa, Shafiee, Abbas, Hashemi, Seyed Mahmoud·2023·Inflammopharmacology
DOI 10.1007/s10787-022-01115-7PMC PMC9823267
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10787-022-01115-7

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 152

  1. Ahmad M, Minhas MU, Sohail M, Faisal M, Rashid H (2013) Comprehensive review on magnetic drug delivery systems: a novel approach for drug targeting. J Pharm Altern Med 2(4):13–21
  2. Akuma P, Okagu OD, Udenigwe CC (2019) Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Front Sustain Food Syst 3:23 · DOI
  3. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341–345 · DOI · Paper page
  4. Antimisiaris SG, Mourtas S, Marazioti A (2018) Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics 10(4):218 · DOI
  5. Armstrong JP, Holme MN, Stevens MM (2017) Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano 11(1):69–83 · DOI
  6. Aryani A, Denecke B (2016) Exosomes as a nanodelivery system: a key to the future of neuromedicine? Mol Neurobiol 53(2):818–834 · DOI
  7. Baek G, Choi H, Kim Y, Lee HC, Choi C (2019) Mesenchymal stem cell-derived extracellular vesicles as therapeutics and as a drug delivery platform. Stem Cells Transl Med 8(9):880–886 · DOI
  8. Bai J, Duan J, Liu R, Du Y, Luo Q, Cui Y et al (2020) Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells. Asian J Pharm Sci 15(4):461–471 · DOI
  9. Balachandran B, Yuana Y (2019) Extracellular vesicles-based drug delivery system for cancer treatment. Cogent Med 6(1):1635806 · DOI
  10. Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, Patinella A et al (2017) Interleukin 3-receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth. Theranostics 7(5):1333 · DOI · Paper page
  11. Brennan MÁ, Layrolle P, Mooney DJ (2020) Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration. Adv Func Mater 30(37):1909125 · DOI
  12. Butreddy A, Kommineni N, Dudhipala N (2021) Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials 11(6):1481 · DOI
  13. Cao Y, Wu T, Zhang K, Meng X, Dai W, Wang D et al (2019) Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano 13(2):1499–1510
  14. Carreira SC, Armstrong J, Seddon A, Perriman A, Hartley-Davies R, Schwarzacher W (2016) Ultra-fast stem cell labelling using cationised magnetoferritin. Nanoscale 8(14):7474–7483 · DOI
  15. Chen D (2021) Potential of surface modified exosomes for extended intravitreal drug delivery. University of Waterloo, Waterloo
  16. Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, Zhou Y (2021a) Exosomes, a new star for targeted delivery. Front Cell Dev Biol 8;9:751079 · DOI
  17. Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, Zhou Y (2021b) Exosomes, a new star for targeted delivery. Front Cell Dev Biol 8;9:751079 · DOI
  18. Cheng H, Fan J-H, Zhao L-P, Fan G-L, Zheng R-R, Qiu X-Z et al (2019) Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy. Biomaterials 211:14–24 · DOI
  19. Choi ES, Song J, Kang YY, Mok H (2019) Mannose-modified serum exosomes for the elevated uptake to murine dendritic cells and lymphatic accumulation. Macromol Biosci 19(7):1900042 · DOI
  20. Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo J-K, Choi C (2021) Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regener Med 18(4):499–511 · DOI
  21. Damasceno PKF, de Santana TA, Santos GC, Orge ID, Silva DN, Albuquerque JF et al (2020) Genetic engineering as a strategy to improve the therapeutic efficacy of mesenchymal stem/stromal cells in regenerative medicine. Front Cell Dev Biol 8:737 · DOI
  22. Das CK, Jena BC, Banerjee I, Das S, Parekh A, Bhutia SK, Mandal M (2018) Exosome as a novel shuttle for delivery of therapeutics across biological barriers. Mol Pharm 16(1):24–40 · DOI
  23. De G, Ko J-K, Tan T, Zhu H, Li H, Ma J (2014) Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment. Oncotarget 5(17):7734 · DOI
  24. de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L (2020) Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol 17(11):685–697 · DOI
  25. Duan L, Ouyang K, Wang J, Xu L, Xu X, Wen C et al (2021) Exosomes as targeted delivery platform of CRISPR/Cas9 for therapeutic genome editing. ChemBioChem 22(24):3360–3368 · DOI · Paper page
  26. Dusoswa SA, Horrevorts SK, Ambrosini M, Kalay H, Paauw NJ, Nieuwland R et al (2019) Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. J Extracell Vesicles 8(1):1648995 · DOI
  27. Dutta A, Paul S (2022) Advancement in Exosome-based cancer therapeutics: a new era in cancer treatment. Front. Nanotechnol 4:939197
  28. Egger D, Tripisciano C, Weber V, Dominici M, Kasper C (2018) Dynamic cultivation of mesenchymal stem cell aggregates. Bioengineering 5(2):48 · DOI
  29. Einabadi M, Ai J, Kargar M, Kafilzadeh F, Taghdiri Nooshabadi V, Jamali H (2020) Mesenchymal cell-derived exosomes as novel useful candidates for drug delivery. Arch Neurosci 7(2) · DOI
  30. Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, Vader P (2020) Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev 159:332–343 · DOI
  31. Ferrero-Andrés A, Closa D, Roselló-Catafau J, Folch-Puy E (2020) Polyethylene glycol 35 (PEG35) modulates exosomal uptake and function. Polymers 12(12):3044 · DOI
  32. Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35–44 · DOI
  33. García-Manrique P, Matos M, Gutiérrez G, Pazos C, Blanco-López MC (2018) Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes. J Extracell Vesicles 7(1):1422676 · DOI
  34. Gebeyehu A, Kommineni N, Meckes Jr DG, Sachdeva MS (2021) Role of exosomes for delivery of chemotherapeutic drugs. Crit Rev Ther Drug Carrier Syst 38(5):53–97 · DOI
  35. Ghitman J, Biru EI, Stan R, Iovu H (2020) Review of hybrid PLGA nanoparticles: future of smart drug delivery and theranostics medicine. Mater Des 193:108805 · DOI
  36. Gilligan KE, Dwyer RM (2017) Engineering exosomes for cancer therapy. Int J Mol Sci 18(6):1122 · DOI · Paper page
  37. Goh WJ, Zou S, Lee CK, Ou Y-H, Wang J-W, Czarny B, Pastorin G (2018) EXOPLEXs: chimeric drug delivery platform from the fusion of cell-derived nanovesicles and liposomes. Biomacromol 19(1):22–30 · DOI
  38. Gomari H, Moghadam MF, Soleimani M (2018) Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle. Onco Targets Ther 11:5753 · DOI
  39. Gorshkov A, Purvinsh L, Brodskaia A, Vasin A (2022) Exosomes as natural nanocarriers for RNA-based therapy and prophylaxis. Nanomaterials 12(3):524 · DOI
  40. Guix FX, Sannerud R, Berditchevski F, Arranz AM, Horré K, Snellinx A et al (2017) Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments. Mol Neurodegener 12(1):1–21 · DOI
  41. Han Y, Jones TW, Dutta S, Zhu Y, Wang X, Narayanan SP et al (2021) Overview and update on methods for cargo loading into extracellular vesicles. Processes 9(2):356 · DOI
  42. He J, Ren W, Wang W, Han W, Jiang L, Zhang D, Guo M (2021) Exosomal targeting and its potential clinical application. Drug Deliv Transl Res 12(10):2385–2402 · DOI
  43. Hessvik NP, Øverbye A, Brech A, Torgersen ML, Jakobsen IS, Sandvig K, Llorente A (2016) PIKfyve inhibition increases exosome release and induces secretory autophagy. Cell Mol Life Sci 73(24):4717–4737 · DOI · Paper page
  44. Hood JL (2016) Post isolation modification of exosomes for nanomedicine applications. Nanomedicine 11(13):1745–1756 · DOI
  45. Hu L, Wickline SA, Hood JL (2015) Magnetic resonance imaging of melanoma exosomes in lymph nodes. Magn Reson Med 74(1):266–271 · DOI
  46. Hwang DW, Jo MJ, Lee JH, Kang H, Bao K, Hu S et al (2019) Chemical modulation of bioengineered exosomes for tissue-specific biodistribution. Adv Ther 2(11):1900111 · DOI
  47. Jafari D, Malih S, Eini M, Jafari R, Gholipourmalekabadi M, Sadeghizadeh M, Samadikuchaksaraei A (2020) Improvement, scaling-up, and downstream analysis of exosome production. Crit Rev Biotechnol 40(8):1098–1112 · DOI
  48. Jang SC, Gho YS (2014) Could bioengineered exosome-mimetic nanovesicles be an efficient strategy for the delivery of chemotherapeutics? Nanomedicine 9(2):177–180 · DOI
  49. Jia G, Han Y, An Y, Ding Y, He C, Wang X, Tang Q (2018) NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials 178:302–316 · DOI · Paper page
  50. Jia X, Tang J, Yao C, Yang D (2021) Recent progress of extracellular vesicle engineering. ACS Biomater Sci Eng 7(9):4430–4438 · DOI
  51. Jiang Y, Zhang P, Zhang X, Lv L, Zhou Y (2020) Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Prolif 54(1):e12956 · DOI
  52. Johnsen KB, Gudbergsson JM, Skov MN, Christiansen G, Gurevich L, Moos T, Duroux M (2016) Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology 68(5):2125–2138 · DOI
  53. Kanuma T, Yamamoto T, Kobiyama K, Moriishi E, Masuta Y, Kusakabe T et al (2017) CD63-mediated antigen delivery into extracellular vesicles via DNA vaccination results in robust CD8+ T cell responses. J Immunol 198(12):4707–4715 · DOI
  54. Kim JY, Song J, Jung H, Mok H (2018a) I-motif-coated exosomes as a pH-sensitive carrier for anticancer drugs. Appl Biol Chem 61(6):599–606 · DOI
  55. Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL et al (2018b) Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomed Nanotechnol Biol Med 14(1):195–204 · DOI · Paper page
  56. Kim G, Kim M, Lee Y, Byun JW, Lee M (2020) Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release 317:273–281 · DOI
  57. Kim G, Lee Y, Ha J, Han S, Lee M (2021a) Engineering exosomes for pulmonary delivery of peptides and drugs to inflammatory lung cells by inhalation. J Control Release 330:684–695 · DOI
  58. Kim H, Jang H, Cho H, Choi J, Hwang KY, Choi Y et al (2021b) Recent advances in exosome-based drug delivery for cancer therapy. Cancers 13(17):4435 · DOI · Paper page
  59. Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM (2012) Exosome mimetics: a novel class of drug delivery systems. Int J Nanomed 7:1525
  60. Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM (2016) Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles 5(1):31053 · DOI
  61. Kooijmans SA, Gitz-Francois JJ, Schiffelers RM, Vader P (2018) Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach. Nanoscale 10(5):2413–2426 · DOI
  62. Kučuk N, Primožič M, Knez Ž, Leitgeb M (2021) Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers. Int J Mol Sci 22(17):9543 · DOI
  63. Laulagnier K, Grand D, Dujardin A, Hamdi S, Vincent-Schneider H, Lankar D et al (2004) PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett 572(1–3):11–14 · DOI
  64. Lee B-C, Kang K-S (2020) Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application. Stem Cell Res Ther 11(1):1–10 · DOI
  65. Lee B-C, Kang I, Yu K-R (2021) Therapeutic features and updated clinical trials of mesenchymal stem cell (MSC)-derived exosomes. J Clin Med 10(4):711 · DOI
  66. Lee J, Lee J-H, Chakraborty K, Hwang J, Lee Y-K (2022) Exosome-based drug delivery systems and their therapeutic applications. RSC Adv 12(29):18475–18492 · DOI
  67. Li Y, Gao Y, Gong C, Wang Z, Xia Q, Gu F et al (2018a) A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer. Nanomed Nanotechnol Biol Med 14(7):1973–1985 · DOI
  68. Li Z, Zhou X, Gao X, Bai D, Dong Y, Sun W et al (2020) Fusion protein engineered exosomes for targeted degradation of specific RNAs in lysosomes: a proof-of-concept study. J Extracell Vesicles 9(1):1816710 · DOI
  69. Liang G, Kan S, Zhu Y, Feng S, Feng W, Gao S (2018) Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomed 13:585 · DOI · Paper page
  70. Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K et al (2020a) Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol 18(1):1–15 · DOI
  71. Liao W, Du Y, Zhang C, Pan F, Yao Y, Zhang T, Peng Q (2019) Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater 86:1–14 · DOI
  72. Limoni SK, Moghadam MF, Moazzeni SM, Gomari H, Salimi F (2019) Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells. Appl Biochem Biotechnol 187(1):352–364 · DOI
  73. Liu C, Su C (2019) Design strategies and application progress of therapeutic exosomes. Theranostics 9(4):1015 · DOI
  74. Liu J, Ye Z, Xiang M, Chang B, Cui J, Ji T et al (2019) Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance. Biomaterials 223:119475 · DOI
  75. Liu M, Fang X, Yang Y, Wang C (2021) Peptide-enabled targeted delivery systems for therapeutic applications. Front Bioeng Biotechnol 9:701504 · DOI
  76. Longatti A, Schindler C, Collinson A, Jenkinson L, Matthews C, Fitzpatrick L et al (2018) High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles. Nanoscale 10(29):14230–14244 · DOI
  77. Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38(6):754–763 · DOI
  78. Marbán E (2018) The secret life of exosomes: what bees can teach us about next-generation therapeutics. J Am Coll Cardiol 71(2):193–200 · DOI
  79. Maumus M, Rozier P, Boulestreau J, Jorgensen C, Noël D (2020) Mesenchymal stem cell-derived extracellular vesicles: opportunities and challenges for clinical translation. Front Bioeng Biotechnol 8:997 · DOI · Paper page
  80. McAndrews KM, Xiao F, Chronopoulos A, LeBleu VS, Kugeratski FG, Kalluri R (2021) Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer. Life Sci Alliance 19;4(9):e202000875 · DOI · Paper page
  81. Meng W, He C, Hao Y, Wang L, Li L, Zhu G (2020) Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv 27(1):585–598 · DOI · Paper page
  82. Mentkowski KI, Lang JK (2019) Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci Rep 9(1):1–13 · DOI · Paper page
  83. Meyer C, Losacco J, Stickney Z, Li L, Marriott G, Lu B (2017) Pseudotyping exosomes for enhanced protein delivery in mammalian cells. Int J Nanomed 12:3153 · DOI
  84. Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T (2015) Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein. Mol Pharm 12(7):2429–2435 · DOI
  85. Modani S, Tomar D, Tangirala S, Sriram A, Mehra NK, Kumar R et al (2021) An updated review on exosomes: biosynthesis to clinical applications. J Drug Target 29(9):925–940 · DOI
  86. Moloudizargari M, Asghari MH, Jørgensen MM, Reiter RJ, Kabelitz D (2022) Extracellular vesicles in cancer immunosurveillance. Front Immunol 13:993967 · DOI
  87. Montaner-Tarbes S, Fraile L, Montoya M, Del Portillo H (2021) Exosome-based vaccines: pros and cons in the world of animal health. Viruses 13:1499 (s Note: MDPI stays neutral with regard to jurisdictional claims in published…) · DOI
  88. Morishita M, Takahashi Y, Matsumoto A, Nishikawa M, Takakura Y (2016) Exosome-based tumor antigens—adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials 111:55–65 · DOI
  89. Mosquera-Heredia MI, Morales LC, Vidal OM, Barceló E, Silvera-Redondo C, Vélez JI, Garavito-Galofre P (2021) Exosomes: potential disease biomarkers and new therapeutic targets. Biomedicines 9(8):1061 · DOI
  90. N’Diaye E-R, Orefice NS, Ghezzi C, Boumendjel A (2022) Chemically modified extracellular vesicles and applications in radiolabeling and drug delivery. Pharmaceutics 14(3):653 · DOI
  91. Nakase I, Futaki S (2015) Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci Rep 5(1):1–13 · DOI
  92. Nan W, Zhang C, Wang H, Chen H, Ji S (2022) Direct modification of extracellular vesicles and its applications for cancer therapy: a mini-review. Front Chem 11;10:910341 · DOI
  93. Nel AE, Mädler L, Velegol D, Xia T, Hoek E, Somasundaran P et al (2009) Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater 8(7):543–557 · DOI · Paper page
  94. Ohno S-I, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N et al (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21(1):185–191 · DOI · Paper page
  95. Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F (2021a) Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res 8;31:61–74 · DOI
  96. Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F (2021b) Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res 31:61–74 · DOI
  97. Park K (2013) Facing the truth about nanotechnology in drug delivery. ACS Nano 7(9):7442–7447 · DOI
  98. Perocheau D, Touramanidou L, Gurung S, Gissen P, Baruteau J (2021) Clinical applications for exosomes: are we there yet? Br J Pharmacol 178(12):2375–2392 · DOI · Paper page
  99. Pham TC, Jayasinghe MK, Pham TT, Yang Y, Wei L, Usman WM et al (2021) Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery. J Extracell Vesicles 10(4):e12057 · DOI · Paper page
  100. Phan J, Kumar P, Hao D, Gao K, Farmer D, Wang A (2018) Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles 7(1):1522236 · DOI
  101. Pi F, Binzel DW, Lee TJ, Li Z, Sun M, Rychahou P et al (2018) Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol 13(1):82–89 · DOI
  102. Podolak I, Galanty A, Sobolewska D (2010) Saponins as cytotoxic agents: a review. Phytochem Rev 9(3):425–474 · DOI
  103. Qi H, Liu C, Long L, Ren Y, Zhang S, Chang X et al (2016) Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano 10(3):3323–3333 · DOI · Paper page
  104. Qu Y, Dubyak GR (2009) P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal 5(2):163–173 · DOI
  105. Rahbarghazi R, Jabbari N, Sani NA, Asghari R, Salimi L, Kalashani SA et al (2019) Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications. Cell Commun Signal 17(1):1–17 · DOI
  106. Rayamajhi S, Aryal S (2020) Surface functionalization strategies of extracellular vesicles. J Mater Chem B 8(21):4552–4569 · DOI
  107. Richardson JJ, Ejima H (2019) Surface engineering of extracellular vesicles through chemical and biological strategies. Chem Mater 31(7):2191–2201 · DOI
  108. Sadeghi S, Mosaffa N, Hashemi SM, Naghizadeh MM, Ghazanfari T (2020a) The immunomodulatory effects of mesenchymal stem cells on long term pulmonary complications in an animal model exposed to a sulfur mustard analog. Int Immunopharmacol 80:105879 · DOI
  109. Sadeghi S, Soudi S, Shafiee A, Hashemi SM (2020b) Mesenchymal stem cell therapies for COVID-19: current status and mechanism of action. Life Sci 1; 262:118493 · DOI
  110. Said Hassane F, Frisch B, Schuber F (2006) Targeted liposomes: convenient coupling of ligands to preformed vesicles using “click chemistry.” Bioconjug Chem 17(3):849–854 · DOI
  111. Sajnani SLP, Zhang Y, Vllasaliu D (2021) Exosome-based therapies for mucosal delivery. Int J Pharm 25;608:121087 · DOI
  112. Salunkhe S, Basak M, Chitkara D, Mittal A (2020) Surface functionalization of exosomes for target-specific delivery and in vivo imaging and tracking: strategies and significance. J Control Release 326:599–614 · DOI
  113. Sancho-Albero M, Medel-Martínez A, Martín-Duque P (2020) Use of exosomes as vectors to carry advanced therapies. RSC Adv 10(40):23975–23987 · DOI
  114. Santos P, Almeida F (2021) Exosome-based vaccines: history, current state, and clinical trials. 14;12:711565 · DOI
  115. Sato YT, Umezaki K, Sawada S, Mukai S-A, Sasaki Y, Harada N et al (2016) Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 6(1):1–11 · DOI · Paper page
  116. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286 · DOI
  117. Shafiee A, Moradi L, Lim M, Brown J (2021) Coronavirus disease 2019: a tissue engineering and regenerative medicine perspective. Stem Cells Transl Med 10(1):27–38 · DOI
  118. Shafiei M, Ansari MNM, Razak SIA, Khan MUA (2021) A comprehensive review on the applications of exosomes and liposomes in regenerative medicine and tissue engineering. Polymers 13(15):2529 · DOI
  119. Syn NL, Wang L, Chow EK-H, Lim CT, Goh B-C (2017) Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol 35(7):665–676 · DOI
  120. Taghavi-Farahabadi M, Mahmoudi M, Rezaei N, Hashemi SM (2021) Wharton’s Jelly mesenchymal stem cells exosomes and conditioned media increased neutrophil lifespan and phagocytosis capacity. Immunol Invest 50(8):1042–1057 · DOI
  121. Taiariol L, Chaix C, Farre C, Moreau E (2021) Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines? Chem Rev 122(1):340–384 · DOI
  122. Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y (2013) Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 165(2):77–84 · DOI
  123. Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569–579 · DOI
  124. Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ et al (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35(7):2383–2390 · DOI
  125. Tian T, Zhang H-X, He C-P, Fan S, Zhu Y-L, Qi C et al (2018) Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials 150:137–149 · DOI · Paper page
  126. Von Schulze A, Deng F (2020) A review on exosome-based cancer therapy. J Cancer Metastasis Treat 6:42
  127. Vymetalova L, Kucirkova T, Knopfova L, Pospisilova V, Kasko T, Lejdarova H et al (2020) Large-scale automated hollow-fiber bioreactor expansion of umbilical cord-derived human mesenchymal stromal cells for neurological disorders. Neurochem Res 45(1):204–214 · DOI
  128. Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J et al (2018) Aptamer-conjugated extracellular nanovesicles for targeted drug delivery preparation of cancer-targeted extracellular nanovesicles. Can Res 78(3):798–808 · DOI
  129. Wang J, Li W, Lu Z, Zhang L, Hu Y, Li Q et al (2017a) The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis. Nanoscale 9(40):15598–15605 · DOI
  130. Wang J, Li W, Zhang L, Ban L, Chen P, Du W et al (2017b) Chemically edited exosomes with dual ligand purified by microfluidic device for active targeted drug delivery to tumor cells. ACS Appl Mater Interfaces 9(33):27441–27452 · DOI
  131. Wang X, Chen Y, Zhao Z, Meng Q, Yu Y, Sun J et al (2018) Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc 7(15):e008737 · DOI
  132. Wang K, Li Y, Ren C, Wang Y, He W, Jiang Y (2021) Extracellular vesicles as innovative treatment strategy for amyotrophic lateral sclerosis. Fron Cell Dev Biol 9:754630–754630 · DOI
  133. Wei H, Chen Q, Lin L, Sha C, Li T, Liu Y et al (2021a) Regulation of exosome production and cargo sorting. Int J Biol Sci 17(1):163 · DOI · Paper page
  134. Wei W, Ao Q, Wang X, Cao Y, Liu Y, Zheng SG, Tian X (2021b) Mesenchymal stem cell-derived exosomes: a promising biological tool in nanomedicine. Front Pharmacol 11:1954 · DOI
  135. Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L (2021) Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 14(1):1–22 · DOI
  136. White MK, Kaminski R, Young WB, Roehm PC, Khalili K (2017) CRISPR editing technology in biological and biomedical investigation. J Cell Biochem 118(11):3586–3594 · DOI
  137. Willms E, Cabañas C, Mäger I, Wood MJ, Vader P (2018) Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol 9:738 · DOI
  138. Wu Z, He D, Li H (2021) Bioglass enhances the production of exosomes and improves their capability of promoting vascularization. Bioact Mater 6(3):823–835 · DOI
  139. Xu Y, Chen C, Hellwarth PB, Bao X (2019) Biomaterials for stem cell engineering and biomanufacturing. Bioact Mater 4:366–379 · DOI
  140. Xu M, Yang Q, Sun X, Wang Y (2020) Recent advancements in the loading and modification of therapeutic exosomes. Front Bioeng Biotechnol 11;8:586130 · DOI
  141. Yamashita T, Takahashi Y, Takakura Y (2018) Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol Pharm Bull 41(6):835–842 · DOI
  142. Yang Y, Hong Y, Cho E, Kim GB, Kim I-S (2018) Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery. J Extracell Vesicles 7(1):1440131 · DOI
  143. Ye Z, Zhang T, He W, Jin H, Liu C, Yang Z, Ren J (2018) Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme. ACS Appl Mater Interfaces 10(15):12341–12350 · DOI
  144. Yu X, Yang X, Horte S, Kizhakkedathu JN, Brooks DE (2014) A pH and thermosensitive choline phosphate-based delivery platform targeted to the acidic tumor microenvironment. Biomaterials 35(1):278–286 · DOI
  145. Zhang S, Zhu D, Mei X, Li Z, Li J, Xie M et al (2021a) Advances in biomaterials and regenerative medicine for primary ovarian insufficiency therapy. Bioact Mater 6(7):1957–1972 · DOI
  146. Zhang X, Zhang H, Gu J, Zhang J, Shi H, Qian H et al (2021b) Engineered extracellular vesicles for cancer therapy. Adv Mater 33(14):2005709 · DOI · Paper page
  147. Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X et al (2019) Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res 115(7):1205–1216 · DOI
  148. Zhou Y, Yuan Y, Liu M, Hu X, Quan Y, Chen X (2019) Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth. ExRNA 1(1):1–7 · DOI
  149. Zhu L, Dong D, Yu Z-L, Zhao Y-F, Pang D-W, Zhang Z-L (2017) Folate-engineered microvesicles for enhanced target and synergistic therapy toward breast cancer. ACS Appl Mater Interfaces 9(6):5100–5108 · DOI
  150. Zhuang M, Chen X, Du D, Shi J, Deng M, Long Q et al (2020) SPION decorated exosome delivery of TNF-α to cancer cell membranes through magnetism. Nanoscale 12(1):173–188 · DOI
  151. Zimmermann J, McDevitt T (2018) Engineering the 3D MSC spheroid microenvironment to enhance immunomodulation. Cytotherapy 20(5):S106 · DOI
  152. Zou J, Shi M, Liu X, Jin C, Xing X, Qiu L, Tan W (2019) Aptamer-functionalized exosomes: elucidating the cellular uptake mechanism and the potential for cancer-targeted chemotherapy. Anal Chem 91(3):2425–2430 · DOI

Cited by

Sorted by citations

See all 351

Metadata

Authors
Sadeghi, S., Tehrani, F. R., Tahmasebi, S., Shafiee, A., & Hashemi, S. M.
Venue
Inflammopharmacology
Publisher
Springer Science and Business Media LLC
Published
2023-01-07
Volume
31
Issue
1
Pages
145-169
ISSN
  • 0925-4692
  • 1568-5608
DOI
10.1007/s10787-022-01115-7
PMC
PMC9823267
Cited by
351
References
13
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exosome engineering in cell therapy and drug delivery. https://app.cochat.ai/papers/10.1007/s10787-022-01115-7
The paper
Sadeghi, S., Tehrani, F. R., Tahmasebi, S., Shafiee, A., & Hashemi, S. M. (2023). Exosome engineering in cell therapy and drug delivery. Inflammopharmacology. https://doi.org/10.1007/s10787-022-01115-7